King Mswati III & Remdesivir: How Eswatini Saved Its King From COVID-19

King Mswati III of Eswatini was hospitalized in emergency condition at a private medical facility in Manzana, according to sources close to the royal family. The 56-year-old monarch’s health reportedly deteriorated significantly, raising concerns among citizens and political observers about the kingdom’s future leadership.

The hospitalization comes after reports surfaced in 2021 that King Mswati III had been treated with the antiviral drug remdesivir during the COVID-19 pandemic. Investigations by Eswatini News indicated the king had publicly praised the drug’s efficacy, coinciding with a surge in global demand for remdesivir due to rising cases and deaths in India.

Mswati III ascended to the throne in 1986, succeeding his father, Sobhuza II. As Ngwenyama, or King, of Eswatini, he holds absolute political authority, with veto power over all branches of government and constitutional immunity from prosecution. He as well serves as commander-in-chief of the defense force and commissioner-in-chief of police and correctional services. Alongside his mother, Queen Ntfombi, Mswati III is the last remaining absolute monarch in Africa.

Insiders report that doctors opted to treat the king locally, citing risks associated with transferring him abroad. The specifics of his condition have not been disclosed, consistent with Eswatini’s tradition of privacy regarding royal health matters. The king’s recent public appearances had reportedly caused alarm, with observers noting noticeable weight loss and a frail demeanor.

The king’s incapacitation could raise constitutional and political questions, particularly given the absence of a publicly defined succession plan. His family consists of over a dozen wives and more than 30 children, adding complexity to the royal line of succession. Analysts have warned that without formal mechanisms in place, internal power struggles within the royal household could jeopardize national unity and political stability.

As of Monday, March 2, 2026, the Eswatini government has remained silent on the matter, reinforcing concerns over a lack of transparency.